Table 6Assessing the Patient for Category A Agents (Continued)Pathogen(incubation period)Systemic symptomsCentral nervoussystemCardiorespiratoryGastrointestinalSkin and mucousmembranesMiscellaneousGastrointestinalanthrax(1–7 daysalthough commonly3–7 days)Nausea, vomiting,anorexia, fever,abdominal pain,hematemesis,bloody diarrhea.An eschar forms on the wallof the intestine, usuallythe terminal ileum orcaecum. Untreated, deathin 2–5 days, (25–60%mortality). Rare patientssuccumb within hours.Anthrax meningitis5% of anthrax casesinvolve meningitisor hemorrhagicmeningoencephalitis.CT and MRI revealfocal intracerebralhemorrhage withleptomeningealenhancement.25% of casesdevelop frominhalationanthrax.The majority ofanthrax meningitiscases developedfrom cutaneousdisease.No primary focuscan be foundin 10% of cases.An anthrax bioterrorist attack may result in all five forms of anthrax in a single patient or any permutation or combination of disease presenting in patients appearingsimultaneously or sequentially to a single institution or area institutions!Botulism(C. botulinum toxin)C. botulinum,
C.barattii,C.butyricum,
C.argentinensetoxinsA–G. (12–80 hr byinhalation;immediate to 12–72hr—range 2–8 daysby ingestion). Mostnaturally occurringhuman disease iscaused by types A,B, and E (Eassociated with fish;type C and D oftencause disease inmammals andbirds).Patients are afebrileand fatigue iscommon (77%).Typically causescranial nerveparalysis [facialparalysis (63%);gaze paralysis(65%); tongueweakness (58%);decreased gag(65%)] withoutaffection sensation.Double vision (91%);blurred vision (65%);pupils fixed anddilated pupils (40%);nystagmus (22%);ptosis (73%); slurredspeech, dizziness(51%); weakness(69–73%); unsteadygait, descendingweakness, flaccidparalysis with fullconsciousness(90%) untilrespiratory failure;paresthesias (14%);ataxia (17%).Dyspnea (60%);sensation of asore throat (54%).Dysphagia (96%);constipation (73%);nausea (64%);vomiting 59%;abdominal cramps(42%); diarrhea(19%).Increased mucousproduction in mouthand throat and/ordry mouth (93%)and throat.444 Cleri et al.
